Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

While Its Price Won’t Soar, Pfizer Stock Is a Fantastic Long-Term Buy

By Larry Ramer, InvestorPlace Contributor

Pfizer has a strong pipeline and an attractive dividend yield, making PFe stock attractive for certain types of investors.

5 Top Stocks for 2021 and Its Rapidly Growing Trends

By Larry Ramer, InvestorPlace Contributor

All of these names should benefit from powerful trends in the market and are trading at reasonable valuations. Here are my five top stocks for 2021.

The Weakness of Boeing Stock Has Created a Buying Opportunity

By Larry Ramer, InvestorPlace Contributor

The worries about Boeing stock are overdone at this point.

Headwinds and High Valuation Should Make You Skittish on Square Stock

By Larry Ramer, InvestorPlace Contributor

Square stock has a market capitalization of nearly $100 billion, and Square could be hurt by increasing competition in coming quarters.

Palantir Stock Is Facing Many More Hurdles Than Just Overvaluation

By Larry Ramer, InvestorPlace Contributor

Palantir appears to lack compelling competitive advantages, while the valuation of Palantir stock is very high.

Why Ayro Stock Still Looks Like an EV Winner

By Larry Ramer, InvestorPlace Contributor

Ayro is likely to sell many of its food-delivery trucks over the longer term, greatly boosting AYRO stock

Newborn Acquisition Stock Looks Intriguing

By Larry Ramer, InvestorPlace Contributor

Although Newborn Acquisition could be a huge winner, the risk-reward ratio of NBAC stock doesn't appear to be attractive for investors yet.

Pfizer’s All-in Costs Show Vaccine Probably Won’t Move the Needle Much

By Larry Ramer, InvestorPlace Contributor

For all the hoopla, PFE stock has already seen the benefit of the Covid-19 vaccine and needs new catalysts. Still, long-term investors may want it's healthy dividend.

There’s an Upbeat Buzz Building on Electrameccanica Stock

By Larry Ramer, InvestorPlace Contributor

Wall Street analysts have been issuing bullish notes on SOLO stock, while the CFO is signaling big deals ahead.

DoorDash Stock Looks Meaningfully Overvalued

By Larry Ramer, InvestorPlace Contributor

The company is facing tough competition and a likely post-pandemic letdown, making DASH stock unattractive

Load More